However, as systemic administration of CCN3 does affect the renal system and potentially other organ systems and various cell types, we cannot rule out off target effects such as hypertension that may indirectly impact reduced cardiac function we observed in our experiments. The gene discussed is CCN3; the disease is hypertensive disorder.